Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA FSNUF Peers
See (FSNUF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| FSNUF | $50.29 | +33.29% | 28.3B | 23.72 | $2.12 | +1.84% |
| FSNUY | $12.64 | -0.32% | 113.9B | 23.85 | $0.53 | +1.90% |
| RVLWF | $0.04 | +97.97% | 38.9B | -0.30 | -$0.13 | N/A |
| FMCQF | $58.68 | N/A | 17.2B | 24.55 | $2.39 | +2.44% |
| BDUUY | $32.33 | N/A | 12.8B | 28.36 | $1.14 | +2.79% |
| BDULF | $0.71 | N/A | 11.3B | 23.67 | $0.03 | +3.13% |
| JDHIY | $3.25 | +100.00% | 10.4B | 18.06 | $0.18 | N/A |
| JDHIF | $3.23 | N/A | 10.3B | 26.92 | $0.12 | N/A |
| IHHHF | $1.10 | -7.56% | 9.7B | 15.71 | $0.07 | +1.25% |
| BDUUF | $0.60 | N/A | 9.5B | 20.00 | $0.03 | +3.70% |
Stock Comparison
FSNUF vs FSNUY Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, FSNUY has a market cap of 113.9B. Regarding current trading prices, FSNUF is priced at $50.29, while FSNUY trades at $12.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas FSNUY's P/E ratio is 23.85. In terms of profitability, FSNUF's ROE is +0.02%, compared to FSNUY's ROE of +0.02%. Regarding short-term risk, FSNUF is less volatile compared to FSNUY. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs RVLWF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, RVLWF has a market cap of 38.9B. Regarding current trading prices, FSNUF is priced at $50.29, while RVLWF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas RVLWF's P/E ratio is -0.30. In terms of profitability, FSNUF's ROE is +0.02%, compared to RVLWF's ROE of +3.95%. Regarding short-term risk, FSNUF is more volatile compared to RVLWF. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs FMCQF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, FMCQF has a market cap of 17.2B. Regarding current trading prices, FSNUF is priced at $50.29, while FMCQF trades at $58.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas FMCQF's P/E ratio is 24.55. In terms of profitability, FSNUF's ROE is +0.02%, compared to FMCQF's ROE of +0.04%. Regarding short-term risk, FSNUF is less volatile compared to FMCQF. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs BDUUY Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, BDUUY has a market cap of 12.8B. Regarding current trading prices, FSNUF is priced at $50.29, while BDUUY trades at $32.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas BDUUY's P/E ratio is 28.36. In terms of profitability, FSNUF's ROE is +0.02%, compared to BDUUY's ROE of +0.16%. Regarding short-term risk, FSNUF is less volatile compared to BDUUY. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs BDULF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, BDULF has a market cap of 11.3B. Regarding current trading prices, FSNUF is priced at $50.29, while BDULF trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas BDULF's P/E ratio is 23.67. In terms of profitability, FSNUF's ROE is +0.02%, compared to BDULF's ROE of +0.16%. Regarding short-term risk, FSNUF is less volatile compared to BDULF. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs JDHIY Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, JDHIY has a market cap of 10.4B. Regarding current trading prices, FSNUF is priced at $50.29, while JDHIY trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas JDHIY's P/E ratio is 18.06. In terms of profitability, FSNUF's ROE is +0.02%, compared to JDHIY's ROE of +0.05%. Regarding short-term risk, FSNUF is more volatile compared to JDHIY. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs JDHIF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, JDHIF has a market cap of 10.3B. Regarding current trading prices, FSNUF is priced at $50.29, while JDHIF trades at $3.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas JDHIF's P/E ratio is 26.92. In terms of profitability, FSNUF's ROE is +0.02%, compared to JDHIF's ROE of +0.05%. Regarding short-term risk, FSNUF is less volatile compared to JDHIF. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs IHHHF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, IHHHF has a market cap of 9.7B. Regarding current trading prices, FSNUF is priced at $50.29, while IHHHF trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas IHHHF's P/E ratio is 15.71. In terms of profitability, FSNUF's ROE is +0.02%, compared to IHHHF's ROE of +0.09%. Regarding short-term risk, FSNUF is less volatile compared to IHHHF. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs BDUUF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, BDUUF has a market cap of 9.5B. Regarding current trading prices, FSNUF is priced at $50.29, while BDUUF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas BDUUF's P/E ratio is 20.00. In terms of profitability, FSNUF's ROE is +0.02%, compared to BDUUF's ROE of +0.16%. Regarding short-term risk, FSNUF is less volatile compared to BDUUF. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs RMSYF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, RMSYF has a market cap of 5.5B. Regarding current trading prices, FSNUF is priced at $50.29, while RMSYF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas RMSYF's P/E ratio is 480.00. In terms of profitability, FSNUF's ROE is +0.02%, compared to RMSYF's ROE of +0.18%. Regarding short-term risk, FSNUF is more volatile compared to RMSYF. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs BUGDF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, BUGDF has a market cap of 5B. Regarding current trading prices, FSNUF is priced at $50.29, while BUGDF trades at $6.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas BUGDF's P/E ratio is 24.27. In terms of profitability, FSNUF's ROE is +0.02%, compared to BUGDF's ROE of +0.28%. Regarding short-term risk, FSNUF is less volatile compared to BUGDF. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs RMYHY Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, RMYHY has a market cap of 4.9B. Regarding current trading prices, FSNUF is priced at $50.29, while RMYHY trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas RMYHY's P/E ratio is 533.00. In terms of profitability, FSNUF's ROE is +0.02%, compared to RMYHY's ROE of +0.18%. Regarding short-term risk, FSNUF is less volatile compared to RMYHY. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs ANHGY Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, ANHGY has a market cap of 4B. Regarding current trading prices, FSNUF is priced at $50.29, while ANHGY trades at $5.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas ANHGY's P/E ratio is 23.87. In terms of profitability, FSNUF's ROE is +0.02%, compared to ANHGY's ROE of N/A. Regarding short-term risk, FSNUF is more volatile compared to ANHGY. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs BUHPF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, BUHPF has a market cap of 3.3B. Regarding current trading prices, FSNUF is priced at $50.29, while BUHPF trades at $4.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas BUHPF's P/E ratio is 17.96. In terms of profitability, FSNUF's ROE is +0.02%, compared to BUHPF's ROE of +0.28%. Regarding short-term risk, FSNUF is less volatile compared to BUHPF. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs MCVEF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, MCVEF has a market cap of 3B. Regarding current trading prices, FSNUF is priced at $50.29, while MCVEF trades at $19.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas MCVEF's P/E ratio is 86.22. In terms of profitability, FSNUF's ROE is +0.02%, compared to MCVEF's ROE of +0.06%. Regarding short-term risk, FSNUF is less volatile compared to MCVEF. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs ORPEF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, ORPEF has a market cap of 2.3B. Regarding current trading prices, FSNUF is priced at $50.29, while ORPEF trades at $14.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas ORPEF's P/E ratio is 0.03. In terms of profitability, FSNUF's ROE is +0.02%, compared to ORPEF's ROE of +0.91%. Regarding short-term risk, FSNUF is less volatile compared to ORPEF. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs MCVEY Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, MCVEY has a market cap of 2.2B. Regarding current trading prices, FSNUF is priced at $50.29, while MCVEY trades at $16.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas MCVEY's P/E ratio is 40.37. In terms of profitability, FSNUF's ROE is +0.02%, compared to MCVEY's ROE of +0.06%. Regarding short-term risk, FSNUF is less volatile compared to MCVEY. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs TTALF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, TTALF has a market cap of 1.6B. Regarding current trading prices, FSNUF is priced at $50.29, while TTALF trades at $12.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas TTALF's P/E ratio is 19.33. In terms of profitability, FSNUF's ROE is +0.02%, compared to TTALF's ROE of +0.15%. Regarding short-term risk, FSNUF is more volatile compared to TTALF. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs RYHTY Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, RYHTY has a market cap of 1.5B. Regarding current trading prices, FSNUF is priced at $50.29, while RYHTY trades at $7.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas RYHTY's P/E ratio is -3.97. In terms of profitability, FSNUF's ROE is +0.02%, compared to RYHTY's ROE of +0.00%. Regarding short-term risk, FSNUF is more volatile compared to RYHTY. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs LWSCF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, LWSCF has a market cap of 1.3B. Regarding current trading prices, FSNUF is priced at $50.29, while LWSCF trades at $13.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas LWSCF's P/E ratio is 45.60. In terms of profitability, FSNUF's ROE is +0.02%, compared to LWSCF's ROE of +0.07%. Regarding short-term risk, FSNUF is more volatile compared to LWSCF. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs RHCGF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, RHCGF has a market cap of 1.2B. Regarding current trading prices, FSNUF is priced at $50.29, while RHCGF trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas RHCGF's P/E ratio is -3.27. In terms of profitability, FSNUF's ROE is +0.02%, compared to RHCGF's ROE of -0.02%. Regarding short-term risk, FSNUF is less volatile compared to RHCGF. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs LTGHY Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, LTGHY has a market cap of 1.2B. Regarding current trading prices, FSNUF is priced at $50.29, while LTGHY trades at $3.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas LTGHY's P/E ratio is -23.71. In terms of profitability, FSNUF's ROE is +0.02%, compared to LTGHY's ROE of +0.40%. Regarding short-term risk, FSNUF is less volatile compared to LTGHY. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs LTGHF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, LTGHF has a market cap of 1.2B. Regarding current trading prices, FSNUF is priced at $50.29, while LTGHF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas LTGHF's P/E ratio is 11.70. In terms of profitability, FSNUF's ROE is +0.02%, compared to LTGHF's ROE of +0.29%. Regarding short-term risk, FSNUF is less volatile compared to LTGHF. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs RAFLF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, RAFLF has a market cap of 1.1B. Regarding current trading prices, FSNUF is priced at $50.29, while RAFLF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas RAFLF's P/E ratio is 20.00. In terms of profitability, FSNUF's ROE is +0.02%, compared to RAFLF's ROE of +0.04%. Regarding short-term risk, FSNUF is less volatile compared to RAFLF. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs RHKJF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, RHKJF has a market cap of 1B. Regarding current trading prices, FSNUF is priced at $50.29, while RHKJF trades at $15.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas RHKJF's P/E ratio is 21.55. In terms of profitability, FSNUF's ROE is +0.02%, compared to RHKJF's ROE of +0.03%. Regarding short-term risk, FSNUF is less volatile compared to RHKJF. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs RKAGY Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, RKAGY has a market cap of 1B. Regarding current trading prices, FSNUF is priced at $50.29, while RKAGY trades at $7.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas RKAGY's P/E ratio is 22.50. In terms of profitability, FSNUF's ROE is +0.02%, compared to RKAGY's ROE of +0.03%. Regarding short-term risk, FSNUF is more volatile compared to RKAGY. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs NWKHY Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, NWKHY has a market cap of 1B. Regarding current trading prices, FSNUF is priced at $50.29, while NWKHY trades at $7.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas NWKHY's P/E ratio is 11.64. In terms of profitability, FSNUF's ROE is +0.02%, compared to NWKHY's ROE of +0.13%. Regarding short-term risk, FSNUF is more volatile compared to NWKHY. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs EXETF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, EXETF has a market cap of 877.2M. Regarding current trading prices, FSNUF is priced at $50.29, while EXETF trades at $10.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas EXETF's P/E ratio is 16.35. In terms of profitability, FSNUF's ROE is +0.02%, compared to EXETF's ROE of +0.66%. Regarding short-term risk, FSNUF is less volatile compared to EXETF. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs JXFGF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, JXFGF has a market cap of 755.6M. Regarding current trading prices, FSNUF is priced at $50.29, while JXFGF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas JXFGF's P/E ratio is 14.00. In terms of profitability, FSNUF's ROE is +0.02%, compared to JXFGF's ROE of +0.03%. Regarding short-term risk, FSNUF is less volatile compared to JXFGF. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs WHTCF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, WHTCF has a market cap of 741.6M. Regarding current trading prices, FSNUF is priced at $50.29, while WHTCF trades at $2.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas WHTCF's P/E ratio is -36.63. In terms of profitability, FSNUF's ROE is +0.02%, compared to WHTCF's ROE of -0.03%. Regarding short-term risk, FSNUF is more volatile compared to WHTCF. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs KDGTF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, KDGTF has a market cap of 675.1M. Regarding current trading prices, FSNUF is priced at $50.29, while KDGTF trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas KDGTF's P/E ratio is -1.67. In terms of profitability, FSNUF's ROE is +0.02%, compared to KDGTF's ROE of N/A. Regarding short-term risk, FSNUF is more volatile compared to KDGTF. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs WFHG Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, WFHG has a market cap of 471.2M. Regarding current trading prices, FSNUF is priced at $50.29, while WFHG trades at $7.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas WFHG's P/E ratio is N/A. In terms of profitability, FSNUF's ROE is +0.02%, compared to WFHG's ROE of +0.22%. Regarding short-term risk, FSNUF is less volatile compared to WFHG. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs ORRRY Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, ORRRY has a market cap of 371.5M. Regarding current trading prices, FSNUF is priced at $50.29, while ORRRY trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas ORRRY's P/E ratio is -0.33. In terms of profitability, FSNUF's ROE is +0.02%, compared to ORRRY's ROE of +0.91%. Regarding short-term risk, FSNUF is more volatile compared to ORRRY. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs BTMDW Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, BTMDW has a market cap of 292.9M. Regarding current trading prices, FSNUF is priced at $50.29, while BTMDW trades at $1.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas BTMDW's P/E ratio is 0.05. In terms of profitability, FSNUF's ROE is +0.02%, compared to BTMDW's ROE of -0.19%. Regarding short-term risk, FSNUF is less volatile compared to BTMDW. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs EVGRF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, EVGRF has a market cap of 234.9M. Regarding current trading prices, FSNUF is priced at $50.29, while EVGRF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas EVGRF's P/E ratio is -0.05. In terms of profitability, FSNUF's ROE is +0.02%, compared to EVGRF's ROE of +0.67%. Regarding short-term risk, FSNUF is less volatile compared to EVGRF. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs MFCSF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, MFCSF has a market cap of 217.8M. Regarding current trading prices, FSNUF is priced at $50.29, while MFCSF trades at $11.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas MFCSF's P/E ratio is 7.36. In terms of profitability, FSNUF's ROE is +0.02%, compared to MFCSF's ROE of +0.84%. Regarding short-term risk, FSNUF is less volatile compared to MFCSF. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs MKLNF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, MKLNF has a market cap of 217.6M. Regarding current trading prices, FSNUF is priced at $50.29, while MKLNF trades at $11.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas MKLNF's P/E ratio is 19.23. In terms of profitability, FSNUF's ROE is +0.02%, compared to MKLNF's ROE of +0.15%. Regarding short-term risk, FSNUF is more volatile compared to MKLNF. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs CHHHF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, CHHHF has a market cap of 124.1M. Regarding current trading prices, FSNUF is priced at $50.29, while CHHHF trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas CHHHF's P/E ratio is -49.25. In terms of profitability, FSNUF's ROE is +0.02%, compared to CHHHF's ROE of -0.05%. Regarding short-term risk, FSNUF is more volatile compared to CHHHF. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs VTIAF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, VTIAF has a market cap of 82.8M. Regarding current trading prices, FSNUF is priced at $50.29, while VTIAF trades at $4.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas VTIAF's P/E ratio is -5.94. In terms of profitability, FSNUF's ROE is +0.02%, compared to VTIAF's ROE of +0.11%. Regarding short-term risk, FSNUF is less volatile compared to VTIAF. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs MCIOF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, MCIOF has a market cap of 54M. Regarding current trading prices, FSNUF is priced at $50.29, while MCIOF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas MCIOF's P/E ratio is -1.22. In terms of profitability, FSNUF's ROE is +0.02%, compared to MCIOF's ROE of N/A. Regarding short-term risk, FSNUF is more volatile compared to MCIOF. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs ASSF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, ASSF has a market cap of 45.3M. Regarding current trading prices, FSNUF is priced at $50.29, while ASSF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas ASSF's P/E ratio is -33.33. In terms of profitability, FSNUF's ROE is +0.02%, compared to ASSF's ROE of -6.63%. Regarding short-term risk, FSNUF is more volatile compared to ASSF. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs KONEF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, KONEF has a market cap of 44.3M. Regarding current trading prices, FSNUF is priced at $50.29, while KONEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas KONEF's P/E ratio is N/A. In terms of profitability, FSNUF's ROE is +0.02%, compared to KONEF's ROE of -6.56%. Regarding short-term risk, FSNUF is less volatile compared to KONEF. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs USNU Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, USNU has a market cap of 24.2M. Regarding current trading prices, FSNUF is priced at $50.29, while USNU trades at $1.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas USNU's P/E ratio is -9.42. In terms of profitability, FSNUF's ROE is +0.02%, compared to USNU's ROE of -0.62%. Regarding short-term risk, FSNUF is less volatile compared to USNU. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs HQDA Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, HQDA has a market cap of 18.6M. Regarding current trading prices, FSNUF is priced at $50.29, while HQDA trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas HQDA's P/E ratio is N/A. In terms of profitability, FSNUF's ROE is +0.02%, compared to HQDA's ROE of +0.00%. Regarding short-term risk, FSNUF is more volatile compared to HQDA. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs NVLPF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, NVLPF has a market cap of 18.1M. Regarding current trading prices, FSNUF is priced at $50.29, while NVLPF trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas NVLPF's P/E ratio is 20.70. In terms of profitability, FSNUF's ROE is +0.02%, compared to NVLPF's ROE of +0.08%. Regarding short-term risk, FSNUF is more volatile compared to NVLPF. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs FPCG Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, FPCG has a market cap of 10.3M. Regarding current trading prices, FSNUF is priced at $50.29, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas FPCG's P/E ratio is 0.09. In terms of profitability, FSNUF's ROE is +0.02%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, FSNUF is more volatile compared to FPCG. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs XCRT Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, XCRT has a market cap of 8.1M. Regarding current trading prices, FSNUF is priced at $50.29, while XCRT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas XCRT's P/E ratio is N/A. In terms of profitability, FSNUF's ROE is +0.02%, compared to XCRT's ROE of +2.48%. Regarding short-term risk, FSNUF is less volatile compared to XCRT. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs NUMIF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, NUMIF has a market cap of 7M. Regarding current trading prices, FSNUF is priced at $50.29, while NUMIF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas NUMIF's P/E ratio is -0.36. In terms of profitability, FSNUF's ROE is +0.02%, compared to NUMIF's ROE of -1.95%. Regarding short-term risk, FSNUF is less volatile compared to NUMIF. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs BICX Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, BICX has a market cap of 6.1M. Regarding current trading prices, FSNUF is priced at $50.29, while BICX trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas BICX's P/E ratio is -0.88. In terms of profitability, FSNUF's ROE is +0.02%, compared to BICX's ROE of +0.40%. Regarding short-term risk, FSNUF is less volatile compared to BICX. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs HLYK Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, HLYK has a market cap of 5.6M. Regarding current trading prices, FSNUF is priced at $50.29, while HLYK trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas HLYK's P/E ratio is -1.00. In terms of profitability, FSNUF's ROE is +0.02%, compared to HLYK's ROE of +2.41%. Regarding short-term risk, FSNUF is less volatile compared to HLYK. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs RHEP Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, RHEP has a market cap of 4.8M. Regarding current trading prices, FSNUF is priced at $50.29, while RHEP trades at $2.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas RHEP's P/E ratio is -1.06. In terms of profitability, FSNUF's ROE is +0.02%, compared to RHEP's ROE of +1.29%. Regarding short-term risk, FSNUF is less volatile compared to RHEP. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs VLXC Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, VLXC has a market cap of 4.8M. Regarding current trading prices, FSNUF is priced at $50.29, while VLXC trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas VLXC's P/E ratio is -6.70. In terms of profitability, FSNUF's ROE is +0.02%, compared to VLXC's ROE of +0.68%. Regarding short-term risk, FSNUF is less volatile compared to VLXC. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs GBCS Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, GBCS has a market cap of 4.6M. Regarding current trading prices, FSNUF is priced at $50.29, while GBCS trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas GBCS's P/E ratio is -2.22. In terms of profitability, FSNUF's ROE is +0.02%, compared to GBCS's ROE of +0.56%. Regarding short-term risk, FSNUF is less volatile compared to GBCS. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs GRST Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, GRST has a market cap of 2.7M. Regarding current trading prices, FSNUF is priced at $50.29, while GRST trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas GRST's P/E ratio is N/A. In terms of profitability, FSNUF's ROE is +0.02%, compared to GRST's ROE of +0.30%. Regarding short-term risk, FSNUF is less volatile compared to GRST. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs EPWCF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, EPWCF has a market cap of 2.5M. Regarding current trading prices, FSNUF is priced at $50.29, while EPWCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas EPWCF's P/E ratio is N/A. In terms of profitability, FSNUF's ROE is +0.02%, compared to EPWCF's ROE of +0.00%. Regarding short-term risk, FSNUF is less volatile compared to EPWCF. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs JRSS Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, JRSS has a market cap of 1.9M. Regarding current trading prices, FSNUF is priced at $50.29, while JRSS trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas JRSS's P/E ratio is -0.37. In terms of profitability, FSNUF's ROE is +0.02%, compared to JRSS's ROE of +2.63%. Regarding short-term risk, FSNUF is more volatile compared to JRSS. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs TOKIF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, TOKIF has a market cap of 1.8M. Regarding current trading prices, FSNUF is priced at $50.29, while TOKIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas TOKIF's P/E ratio is -0.01. In terms of profitability, FSNUF's ROE is +0.02%, compared to TOKIF's ROE of -0.83%. Regarding short-term risk, FSNUF is less volatile compared to TOKIF. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs SMAS Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, SMAS has a market cap of 1.5M. Regarding current trading prices, FSNUF is priced at $50.29, while SMAS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas SMAS's P/E ratio is N/A. In terms of profitability, FSNUF's ROE is +0.02%, compared to SMAS's ROE of N/A. Regarding short-term risk, FSNUF is less volatile compared to SMAS. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs MDGP Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, MDGP has a market cap of 1.5M. Regarding current trading prices, FSNUF is priced at $50.29, while MDGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas MDGP's P/E ratio is N/A. In terms of profitability, FSNUF's ROE is +0.02%, compared to MDGP's ROE of -2.19%. Regarding short-term risk, FSNUF is more volatile compared to MDGP. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs NOVC Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, NOVC has a market cap of 1.2M. Regarding current trading prices, FSNUF is priced at $50.29, while NOVC trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas NOVC's P/E ratio is -0.20. In terms of profitability, FSNUF's ROE is +0.02%, compared to NOVC's ROE of +0.12%. Regarding short-term risk, FSNUF is more volatile compared to NOVC. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs PHMB Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, PHMB has a market cap of 1.1M. Regarding current trading prices, FSNUF is priced at $50.29, while PHMB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas PHMB's P/E ratio is N/A. In terms of profitability, FSNUF's ROE is +0.02%, compared to PHMB's ROE of N/A. Regarding short-term risk, FSNUF is less volatile compared to PHMB. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs GNOW Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, GNOW has a market cap of 859.7K. Regarding current trading prices, FSNUF is priced at $50.29, while GNOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas GNOW's P/E ratio is -0.01. In terms of profitability, FSNUF's ROE is +0.02%, compared to GNOW's ROE of +0.00%. Regarding short-term risk, FSNUF is more volatile compared to GNOW. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs NXGT Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, NXGT has a market cap of 480.8K. Regarding current trading prices, FSNUF is priced at $50.29, while NXGT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas NXGT's P/E ratio is N/A. In terms of profitability, FSNUF's ROE is +0.02%, compared to NXGT's ROE of +0.09%. Regarding short-term risk, FSNUF is more volatile compared to NXGT. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs ARPC Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, ARPC has a market cap of 336.6K. Regarding current trading prices, FSNUF is priced at $50.29, while ARPC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas ARPC's P/E ratio is N/A. In terms of profitability, FSNUF's ROE is +0.02%, compared to ARPC's ROE of -0.56%. Regarding short-term risk, FSNUF is less volatile compared to ARPC. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs JNHMF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, JNHMF has a market cap of 335.9K. Regarding current trading prices, FSNUF is priced at $50.29, while JNHMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas JNHMF's P/E ratio is -0.07. In terms of profitability, FSNUF's ROE is +0.02%, compared to JNHMF's ROE of +0.81%. Regarding short-term risk, FSNUF is less volatile compared to JNHMF. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs SETO Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, SETO has a market cap of 299.4K. Regarding current trading prices, FSNUF is priced at $50.29, while SETO trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas SETO's P/E ratio is -2.40. In terms of profitability, FSNUF's ROE is +0.02%, compared to SETO's ROE of +0.00%. Regarding short-term risk, FSNUF is more volatile compared to SETO. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs FCHS Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, FCHS has a market cap of 283.4K. Regarding current trading prices, FSNUF is priced at $50.29, while FCHS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas FCHS's P/E ratio is -0.07. In terms of profitability, FSNUF's ROE is +0.02%, compared to FCHS's ROE of +0.12%. Regarding short-term risk, FSNUF is less volatile compared to FCHS. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs KJFI Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, KJFI has a market cap of 278.9K. Regarding current trading prices, FSNUF is priced at $50.29, while KJFI trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas KJFI's P/E ratio is -0.06. In terms of profitability, FSNUF's ROE is +0.02%, compared to KJFI's ROE of +0.00%. Regarding short-term risk, FSNUF is more volatile compared to KJFI. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs DPAT Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, DPAT has a market cap of 276.9K. Regarding current trading prices, FSNUF is priced at $50.29, while DPAT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas DPAT's P/E ratio is -1.15. In terms of profitability, FSNUF's ROE is +0.02%, compared to DPAT's ROE of +0.45%. Regarding short-term risk, FSNUF is less volatile compared to DPAT. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs HSMD Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, HSMD has a market cap of 153.4K. Regarding current trading prices, FSNUF is priced at $50.29, while HSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas HSMD's P/E ratio is -0.05. In terms of profitability, FSNUF's ROE is +0.02%, compared to HSMD's ROE of -0.04%. Regarding short-term risk, FSNUF is more volatile compared to HSMD. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs BNYN Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, BNYN has a market cap of 150.5K. Regarding current trading prices, FSNUF is priced at $50.29, while BNYN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas BNYN's P/E ratio is N/A. In terms of profitability, FSNUF's ROE is +0.02%, compared to BNYN's ROE of -14.10%. Regarding short-term risk, FSNUF is less volatile compared to BNYN. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs COLRF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, COLRF has a market cap of 129.5K. Regarding current trading prices, FSNUF is priced at $50.29, while COLRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas COLRF's P/E ratio is -0.01. In terms of profitability, FSNUF's ROE is +0.02%, compared to COLRF's ROE of +0.02%. Regarding short-term risk, FSNUF is more volatile compared to COLRF. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs TPIA Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, TPIA has a market cap of 113.8K. Regarding current trading prices, FSNUF is priced at $50.29, while TPIA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas TPIA's P/E ratio is -0.15. In terms of profitability, FSNUF's ROE is +0.02%, compared to TPIA's ROE of +0.61%. Regarding short-term risk, FSNUF is less volatile compared to TPIA. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs AMBD Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, AMBD has a market cap of 85.6K. Regarding current trading prices, FSNUF is priced at $50.29, while AMBD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas AMBD's P/E ratio is N/A. In terms of profitability, FSNUF's ROE is +0.02%, compared to AMBD's ROE of +1.11%. Regarding short-term risk, FSNUF is less volatile compared to AMBD. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs GENN Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, GENN has a market cap of 49K. Regarding current trading prices, FSNUF is priced at $50.29, while GENN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas GENN's P/E ratio is -0.03. In terms of profitability, FSNUF's ROE is +0.02%, compared to GENN's ROE of +0.00%. Regarding short-term risk, FSNUF is more volatile compared to GENN. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs NMHLY Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, NMHLY has a market cap of 41.7K. Regarding current trading prices, FSNUF is priced at $50.29, while NMHLY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas NMHLY's P/E ratio is 0.02. In terms of profitability, FSNUF's ROE is +0.02%, compared to NMHLY's ROE of N/A. Regarding short-term risk, FSNUF is more volatile compared to NMHLY. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs DRWN Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, DRWN has a market cap of 24K. Regarding current trading prices, FSNUF is priced at $50.29, while DRWN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas DRWN's P/E ratio is N/A. In terms of profitability, FSNUF's ROE is +0.02%, compared to DRWN's ROE of -0.01%. Regarding short-term risk, FSNUF is less volatile compared to DRWN. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs SCAL Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, SCAL has a market cap of 17.4K. Regarding current trading prices, FSNUF is priced at $50.29, while SCAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas SCAL's P/E ratio is 0.04. In terms of profitability, FSNUF's ROE is +0.02%, compared to SCAL's ROE of +0.07%. Regarding short-term risk, FSNUF is more volatile compared to SCAL. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs NAFS Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, NAFS has a market cap of 14K. Regarding current trading prices, FSNUF is priced at $50.29, while NAFS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas NAFS's P/E ratio is N/A. In terms of profitability, FSNUF's ROE is +0.02%, compared to NAFS's ROE of +1.02%. Regarding short-term risk, FSNUF is more volatile compared to NAFS. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs CHCR Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, CHCR has a market cap of 12K. Regarding current trading prices, FSNUF is priced at $50.29, while CHCR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas CHCR's P/E ratio is -0.00. In terms of profitability, FSNUF's ROE is +0.02%, compared to CHCR's ROE of N/A. Regarding short-term risk, FSNUF is more volatile compared to CHCR. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs ACGI Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, ACGI has a market cap of 10.5K. Regarding current trading prices, FSNUF is priced at $50.29, while ACGI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas ACGI's P/E ratio is N/A. In terms of profitability, FSNUF's ROE is +0.02%, compared to ACGI's ROE of +1.11%. Regarding short-term risk, FSNUF is less volatile compared to ACGI. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs CEVE Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, CEVE has a market cap of 7.7K. Regarding current trading prices, FSNUF is priced at $50.29, while CEVE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas CEVE's P/E ratio is N/A. In terms of profitability, FSNUF's ROE is +0.02%, compared to CEVE's ROE of +2.26%. Regarding short-term risk, FSNUF is more volatile compared to CEVE. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs PRMD Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, PRMD has a market cap of 5.6K. Regarding current trading prices, FSNUF is priced at $50.29, while PRMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas PRMD's P/E ratio is N/A. In terms of profitability, FSNUF's ROE is +0.02%, compared to PRMD's ROE of +0.73%. Regarding short-term risk, FSNUF is less volatile compared to PRMD. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs CLRD Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, CLRD has a market cap of 5.4K. Regarding current trading prices, FSNUF is priced at $50.29, while CLRD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas CLRD's P/E ratio is -0.01. In terms of profitability, FSNUF's ROE is +0.02%, compared to CLRD's ROE of +0.38%. Regarding short-term risk, FSNUF is more volatile compared to CLRD. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs MSGP Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, MSGP has a market cap of 5.2K. Regarding current trading prices, FSNUF is priced at $50.29, while MSGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas MSGP's P/E ratio is N/A. In terms of profitability, FSNUF's ROE is +0.02%, compared to MSGP's ROE of +0.27%. Regarding short-term risk, FSNUF is more volatile compared to MSGP. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs MSITF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, MSITF has a market cap of 4.8K. Regarding current trading prices, FSNUF is priced at $50.29, while MSITF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas MSITF's P/E ratio is -0.00. In terms of profitability, FSNUF's ROE is +0.02%, compared to MSITF's ROE of N/A. Regarding short-term risk, FSNUF is more volatile compared to MSITF. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs ERUC Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, ERUC has a market cap of 3.9K. Regarding current trading prices, FSNUF is priced at $50.29, while ERUC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas ERUC's P/E ratio is N/A. In terms of profitability, FSNUF's ROE is +0.02%, compared to ERUC's ROE of N/A. Regarding short-term risk, FSNUF is less volatile compared to ERUC. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs SLHPF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, SLHPF has a market cap of 3.9K. Regarding current trading prices, FSNUF is priced at $50.29, while SLHPF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas SLHPF's P/E ratio is N/A. In terms of profitability, FSNUF's ROE is +0.02%, compared to SLHPF's ROE of +0.00%. Regarding short-term risk, FSNUF is less volatile compared to SLHPF. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs WEQL Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, WEQL has a market cap of 3.5K. Regarding current trading prices, FSNUF is priced at $50.29, while WEQL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas WEQL's P/E ratio is N/A. In terms of profitability, FSNUF's ROE is +0.02%, compared to WEQL's ROE of +0.21%. Regarding short-term risk, FSNUF is more volatile compared to WEQL. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs BBAL Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, BBAL has a market cap of 3.4K. Regarding current trading prices, FSNUF is priced at $50.29, while BBAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas BBAL's P/E ratio is N/A. In terms of profitability, FSNUF's ROE is +0.02%, compared to BBAL's ROE of +0.45%. Regarding short-term risk, FSNUF is more volatile compared to BBAL. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs PAOG Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, PAOG has a market cap of 2.5K. Regarding current trading prices, FSNUF is priced at $50.29, while PAOG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas PAOG's P/E ratio is N/A. In terms of profitability, FSNUF's ROE is +0.02%, compared to PAOG's ROE of +0.08%. Regarding short-term risk, FSNUF is less volatile compared to PAOG. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs NMMCF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, NMMCF has a market cap of 2.1K. Regarding current trading prices, FSNUF is priced at $50.29, while NMMCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas NMMCF's P/E ratio is 0.00. In terms of profitability, FSNUF's ROE is +0.02%, compared to NMMCF's ROE of +0.00%. Regarding short-term risk, FSNUF is less volatile compared to NMMCF. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs PPRG Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, PPRG has a market cap of 1.6K. Regarding current trading prices, FSNUF is priced at $50.29, while PPRG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas PPRG's P/E ratio is N/A. In terms of profitability, FSNUF's ROE is +0.02%, compared to PPRG's ROE of -0.58%. Regarding short-term risk, FSNUF is more volatile compared to PPRG. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs OHAQ Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, OHAQ has a market cap of 1.4K. Regarding current trading prices, FSNUF is priced at $50.29, while OHAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas OHAQ's P/E ratio is 0.01. In terms of profitability, FSNUF's ROE is +0.02%, compared to OHAQ's ROE of +0.09%. Regarding short-term risk, FSNUF is more volatile compared to OHAQ. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs BNKL Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, BNKL has a market cap of 1.2K. Regarding current trading prices, FSNUF is priced at $50.29, while BNKL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas BNKL's P/E ratio is N/A. In terms of profitability, FSNUF's ROE is +0.02%, compared to BNKL's ROE of -7.69%. Regarding short-term risk, FSNUF is more volatile compared to BNKL. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs MAHN Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, MAHN has a market cap of 1.2K. Regarding current trading prices, FSNUF is priced at $50.29, while MAHN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas MAHN's P/E ratio is 0.05. In terms of profitability, FSNUF's ROE is +0.02%, compared to MAHN's ROE of N/A. Regarding short-term risk, FSNUF is less volatile compared to MAHN. This indicates potentially lower risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs SLHGF Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, SLHGF has a market cap of 398. Regarding current trading prices, FSNUF is priced at $50.29, while SLHGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas SLHGF's P/E ratio is -0.00. In terms of profitability, FSNUF's ROE is +0.02%, compared to SLHGF's ROE of +0.00%. Regarding short-term risk, FSNUF is more volatile compared to SLHGF. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs LHRP Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, LHRP has a market cap of 343. Regarding current trading prices, FSNUF is priced at $50.29, while LHRP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas LHRP's P/E ratio is 0.00. In terms of profitability, FSNUF's ROE is +0.02%, compared to LHRP's ROE of N/A. Regarding short-term risk, FSNUF is more volatile compared to LHRP. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.
FSNUF vs NMSCA Comparison
FSNUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FSNUF stands at 28.3B. In comparison, NMSCA has a market cap of 275. Regarding current trading prices, FSNUF is priced at $50.29, while NMSCA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FSNUF currently has a P/E ratio of 23.72, whereas NMSCA's P/E ratio is N/A. In terms of profitability, FSNUF's ROE is +0.02%, compared to NMSCA's ROE of +0.02%. Regarding short-term risk, FSNUF is more volatile compared to NMSCA. This indicates potentially higher risk in terms of short-term price fluctuations for FSNUF.